$IRBT
IROBOT CORP Stock $irbt

$irbt Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000115916722000055 Filed on August 10, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$255.4M	$292.0M	$455.4M
YoY Change	-30.15%	-3.72%	-16.4%
Cost Of Revenue	$174.4M	$184.5M	$329.8M
YoY Change	-23.04%	2.29%	0.13%
Gross Profit	$80.95M	$107.5M	$125.6M
YoY Change	-41.76%	-12.55%	-41.68%
Gross Profit Margin	31.7%	36.82%	27.58%
Selling, General & Admin	$102.4M	$87.76M	$129.7M
YoY Change	-0.72%	17.91%	-16.41%
% of Gross Profit	126.5%	81.63%	103.27%
Research & Development	$41.94M	$42.53M	$40.47M
YoY Change	8.43%	1.45%	-9.46%
% of Gross Profit	51.81%	39.56%	32.22%
Depreciation & Amortization	$8.474M	$11.24M	$9.331M
YoY Change	4.17%	49.86%	2.54%
% of Gross Profit	10.47%	10.46%	7.43%
Operating Expenses	$144.9M	$130.8M	$170.6M
YoY Change	2.0%	12.22%	-14.8%
Operating Profit	-$63.91M	-$23.29M	-$44.95M
YoY Change	2001.05%	-464.49%	-395.69%
Interest Expense	-$1.979M	-$16.84M	$3.134M
YoY Change	691.6%
% of Operating Profit
Other Income/Expense, Net	-$2.182M	-$16.75M	$111.0K
YoY Change	662.94%	10366.25%	-155.5%
Pretax Income	-$66.10M	-$40.03M	-$41.70M
YoY Change	1886.06%	-742.69%	-378.0%
Income Tax	-$22.70M	-$9.600M	-$10.19M
% Of Pretax Income
Net Earnings	-$43.42M	-$30.41M	-$31.51M
YoY Change	1474.37%	-508.52%	-336.92%
Net Earnings / Revenue	-17.0%	-10.41%	-6.92%
Basic Earnings Per Share	-$1.60	-$1.12
Diluted Earnings Per Share	-$1.60	-$1.12	-$1.168M
COMMON SHARES
Basic Shares Outstanding	27.16M shares	27.05M shares	27.03M shares
Diluted Shares Outstanding	27.16M shares	27.05M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$63.41M	$113.5M	$234.5M
YoY Change	-84.75%	-77.34%	-51.52%
Cash & Equivalents	$63.41M	$112.0M	$201.5M
Short-Term Investments	$0.00	$1.461M	$33.04M
Other Short-Term Assets	$111.7M	$96.75M	$61.09M
YoY Change	128.72%	133.87%	35.09%
Inventory	$397.0M	$331.1M	$333.3M
Prepaid Expenses
Receivables	$87.77M	$105.6M	$160.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$659.8M	$646.9M	$789.5M
YoY Change	-19.13%	-23.28%	-10.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$69.29M	$71.88M	$78.89M
YoY Change	-14.62%	-10.6%	3.01%
Goodwill	$164.9M	$170.0M	$173.3M
YoY Change	33.24%	37.88%	37.67%
Intangibles	$24.07M	$26.63M	$28.41M
YoY Change	169.65%	185.94%	186.91%
Long-Term Investments	$16.20M	$15.30M	$16.30M
YoY Change	-10.5%	-12.57%	-6.32%
Other Assets	$59.31M	$38.83M	$38.75M
YoY Change	101.49%	47.91%	103.29%
Total Long-Term Assets	$410.1M	$389.6M	$394.9M
YoY Change	29.01%	23.77%	28.0%
TOTAL ASSETS
Total Short-Term Assets	$659.8M	$646.9M	$789.5M
Total Long-Term Assets	$410.1M	$389.6M	$394.9M
Total Assets	$1.070B	$1.036B	$1.184B
YoY Change	-5.63%	-10.49%	-0.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$192.4M	$172.9M	$251.3M
YoY Change	15.36%	14.68%	51.59%
Accrued Expenses	$91.08M	$89.38M	$132.6M
YoY Change	-12.87%	-15.53%	0.94%
Deferred Revenue
YoY Change
Short-Term Debt	$35.00M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$332.1M	$275.6M	$395.7M
YoY Change	17.45%	4.44%	28.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$23.10M	$25.58M	$25.31M
YoY Change	8.17%	23.52%	-4.62%
Total Long-Term Liabilities	$61.07M	$65.68M	$72.02M
YoY Change	-12.54%	-6.22%	-7.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$332.1M	$275.6M	$395.7M
Total Long-Term Liabilities	$61.07M	$65.68M	$72.02M
Total Liabilities	$393.2M	$341.3M	$467.7M
YoY Change	11.51%	2.2%	21.39%
SHAREHOLDERS EQUITY
Retained Earnings	$411.9M	$455.3M	$485.7M
YoY Change	-26.11%	-24.97%	-18.97%
Common Stock	$239.6M	$229.4M	$222.9M
YoY Change	10.61%	9.15%	8.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$676.8M	$695.2M	$716.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.070B	$1.036B	$1.184B
YoY Change	-5.63%	-10.49%	-0.45%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$43.42M	-$30.41M	-$31.51M
YoY Change	1474.37%	-508.52%	-336.92%
Depreciation, Depletion And Amortization	$8.474M	$11.24M	$9.331M
YoY Change	4.17%	49.86%	2.54%
Cash From Operating Activities	-$84.20M	-$102.3M	$58.81M
YoY Change	212.99%	-456.57%	-56.54%
INVESTING ACTIVITIES
Capital Expenditures	-$1.781M	$3.113M	-$4.626M
YoY Change	-83.24%	-72.38%	-29.91%
Acquisitions
YoY Change
Other Investing Activities	-$1.420M	$500.0K	-$72.53M
YoY Change	47.61%	-94.23%	-2889.5%
Cash From Investing Activities	-$3.201M	$12.60M	-$77.15M
YoY Change	-72.37%	-71.17%	1878.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	37.21M	-$727.0K	1.562M
YoY Change	-178.4%	-66.45%	4.13%
NET CHANGE
Cash From Operating Activities	-84.20M	-$102.3M	58.81M
Cash From Investing Activities	-3.201M	$12.60M	-77.15M
Cash From Financing Activities	37.21M	-$727.0K	1.562M
Net Change In Cash	-50.18M	-$89.42M	-16.79M
YoY Change	-41.62%	-231.27%	-112.63%
FREE CASH FLOW
Cash From Operating Activities	-$84.20M	-$102.3M	$58.81M
Capital Expenditures	-$1.781M	$3.113M	-$4.626M
Free Cash Flow	-$82.42M	-$105.4M	$63.43M
YoY Change	406.33%	-705.14%	-55.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001159167
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-07-02
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36414
	dei	Entity Registrant Name EntityRegistrantName	iROBOT CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0259335
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 Crosby Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bedford
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01730
	dei	City Area Code CityAreaCode	781
	dei	Local Phone Number LocalPhoneNumber	430-3000
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	IRBT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27229605	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63409000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	201457000	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	33044000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	87766000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	160642000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	397012000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	333296000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	111654000	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	61094000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	659841000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	789533000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	69294000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	78887000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29875000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37609000	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	62698000	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	37945000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	164869000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	173292000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24072000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28410000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	59312000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38753000	usd
CY2022Q3	us-gaap	Assets Assets	1069961000	usd
CY2022Q1	us-gaap	Assets Assets	1184429000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	192388000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	251298000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	91084000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132618000	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	13645000	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	11767000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	35000000	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	332117000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	395683000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	35066000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43462000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2904000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3250000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23098000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25311000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	61068000	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	72023000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	393185000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	467706000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27229000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27229000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27006000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27006000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	272000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	270000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	239369000	usd
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	222653000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	411883000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	485710000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	25252000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8090000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	676776000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	716723000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1069961000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1184429000	usd
CY2022Q3	us-gaap	Revenues Revenues	255351000	usd
CY2021Q3	us-gaap	Revenues Revenues	365596000	usd
	us-gaap	Revenues Revenues	547320000	usd
	us-gaap	Revenues Revenues	668857000	usd
CY2022Q3	irbt	Costofproductrevenue Costofproductrevenue	173531000	usd
CY2021Q3	irbt	Costofproductrevenue Costofproductrevenue	226395000	usd
	irbt	Costofproductrevenue Costofproductrevenue	357164000	usd
	irbt	Costofproductrevenue Costofproductrevenue	406487000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	875000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	225000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1696000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	450000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	174406000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	226620000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	358860000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	406937000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	80945000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	138976000	usd
	us-gaap	Gross Profit GrossProfit	188460000	usd
	us-gaap	Gross Profit GrossProfit	261920000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41937000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38677000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	84466000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	80597000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	76017000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	76677000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	137082000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	127668000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26380000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26459000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	53078000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	49899000	usd
CY2022Q3	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	525000	usd
CY2021Q3	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	205000	usd
	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	1035000	usd
	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	409000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	144859000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	142018000	usd
	us-gaap	Operating Expenses OperatingExpenses	275661000	usd
	us-gaap	Operating Expenses OperatingExpenses	258573000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-63914000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3042000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-87201000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3347000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2182000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-286000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18928000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-446000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-66096000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3328000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-106129000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2901000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22675000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-570000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-32302000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1784000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-43421000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2758000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-73827000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4685000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.60
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.60
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27161000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27106000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28178000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27161000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28100000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27106000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28908000	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-43421000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2758000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-73827000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4685000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-7360000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	1114000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-11375000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-4769000	usd
CY2022Q3	irbt	Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax	24934000	usd
CY2021Q3	irbt	Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax	-36000	usd
	irbt	Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax	32587000	usd
	irbt	Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax	12932000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	2816000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	932000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	4050000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	542000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2021Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-4000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28663000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2612000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-56665000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12302000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	695202000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2291000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8023000	usd
CY2022Q3	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	77000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14758000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-43421000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	676776000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	716723000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3088000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15231000	usd
	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	1601000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	17162000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-73827000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	676776000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	823984000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2542000	shares
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7340000	usd
CY2021Q3	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	43000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	146000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	146000	usd
CY2021Q3	irbt	Adjustments To Additional Paid In Capital Directors Deferred Compensation AdjustmentsToAdditionalPaidInCapitalDirectorsDeferredCompensation	21000	usd
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	50000000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2758000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	781232000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	804434000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5131000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14122000	usd
	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	4799000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7617000	usd
	irbt	Adjustments To Additional Paid In Capital Directors Deferred Compensation AdjustmentsToAdditionalPaidInCapitalDirectorsDeferredCompensation	42000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	447000	shares
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	50000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4685000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	781232000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-73827000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4685000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19715000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15635000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-18814000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15231000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	14122000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	35467000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-210000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2844000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3286000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-70372000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-94477000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	70400000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	94918000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	31657000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7554000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-58520000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2071000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-43617000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-30215000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-186512000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1799000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4894000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21924000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	3090000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	9606000	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-17383000	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-63644000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9399000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	32114000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3088000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	5131000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1601000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4799000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	35000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36487000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-49668000	usd
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2578000	usd
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1039000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-138048000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16794000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	201457000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	432635000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63409000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	415841000	usd
	us-gaap	Nature Of Operations NatureOfOperations	Description of Business<div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iRobot Corporation ("iRobot" or the "Company") designs, builds and sells robots and home innovations that make life better. The Company's portfolio of home robots and smart home devices features proprietary technologies for the connected home and advanced concepts in cleaning, mapping and navigation, human-robot interaction and physical solutions. iRobot's durable and high-performing robots are designed using the close integration of software, electronics and hardware. The Company’s revenue is primarily generated from product sales through a variety of distribution channels, including chain stores and other national retailers, through the Company's own website and app, dedicated e-commerce websites, the online arms of traditional retailers and through value-added distributors and resellers worldwide. </span></div><div style="margin-top:5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger Agreement</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2022, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among the Company, Amazon.com, Inc., a Delaware corporation ("Parent" or "Amazon") and Martin Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each share of common stock of the Company, par value $0.01 per share ("Common Stock"), outstanding immediately prior to the effective time of the Merger (the "Effective Time") (subject to certain exceptions, including shares of Common Stock owned by the Company, Merger Sub, Parent or any of their respective direct or indirect wholly owned subsidiaries and shares of Common Stock owned by stockholders of the Company who have validly demanded and not withdrawn appraisal rights in accordance with Section 262 of the General Corporation Law of the State of Delaware) will, at the Effective Time, automatically be cancelled and converted into the right to receive $61.00 in cash, without interest and subject to applicable withholding taxes. If the Merger is consummated, the Company’s Common Stock will be delisted from the Nasdaq Stock Market LLC and deregistered under the Securities Exchange Act of 1934.</span></div>
	us-gaap	Net Income Loss NetIncomeLoss	-73827000	usd
	us-gaap	Fiscal Period FiscalPeriod	The Company operates and reports using a 52-53 week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenue and expenses. These estimates and judgments, include but are not limited to, revenue recognition, including performance obligations, standalone selling price, variable consideration and other obligations such as sales incentives and product returns; allowance for credit losses; accounting for business combinations; impairment of goodwill and long-lived assets; valuation of non-marketable equity investments; product warranties; loss contingencies; accounting for stock-based compensation including performance-based assessments; and accounting for income taxes and related valuation allowances. The Company bases its estimates and assumptions on historical experience, market participant fair value considerations, projected future cash flows, current economic conditions, including impact from COVID-19 pandemic and the uncertainty imposed by the conflict between Russia and Ukraine, and various other </span></div>factors that the Company believes are reasonable under the circumstances. Actual results and outcomes may differ from the Company’s estimates and assumptions.
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	33000000	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6400000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4600000	usd
CY2022Q3	us-gaap	Receivable For Recovery Of Import Duties Net ReceivableForRecoveryOfImportDutiesNet	32000000	usd
CY2022Q3	us-gaap	Receivable For Recovery Of Import Duties Net ReceivableForRecoveryOfImportDutiesNet	32000000	usd
CY2022Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	16200000	usd
CY2022Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	16300000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-43421000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2758000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4685000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27161000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27106000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28178000	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	730000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27161000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28100000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27106000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28908000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.60
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.60
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1300000	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	21300000	usd
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	20900000	usd
CY2022Q3	irbt	Refundliabilityproductreturns Refundliabilityproductreturns	42800000	usd
CY2022Q3	irbt	Refundliabilityothercreditsandincentives Refundliabilityothercreditsandincentives	64300000	usd
CY2022Q1	irbt	Refundliabilityproductreturns Refundliabilityproductreturns	56800000	usd
CY2022Q1	irbt	Refundliabilityothercreditsandincentives Refundliabilityothercreditsandincentives	101600000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	22996000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	255351000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	365596000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	547320000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	668857000	usd
CY2022Q3	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	81318000	usd
CY2022Q1	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	155659000	usd
CY2022Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8799000	usd
CY2022Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8747000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24062000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5800000	usd
CY2021Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3400000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7600000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8900000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	2163000	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	2147000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3014000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	4134000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	1010000	usd
CY2021Q3	us-gaap	Variable Lease Cost VariableLeaseCost	1033000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1928000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1928000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	3173000	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	3180000	usd
	us-gaap	Lease Cost LeaseCost	4942000	usd
	us-gaap	Lease Cost LeaseCost	6062000	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1995000	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	2100000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	4034000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	4379000	usd
CY2022Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0401
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y1M28D
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3582000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7315000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6034000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5781000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5806000	usd
CY2022Q3	irbt	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	18930000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	47448000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6291000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	41157000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6091000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6091000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	35066000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5593000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	173292000	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28410000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-583000	usd
	us-gaap	Finite Lived Intangible Assets Purchase Accounting Adjustments FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2731000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-7840000	usd
	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-1607000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	164869000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24072000	usd
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2600000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	26814000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	32019000	usd
CY2022Q3	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	20713000	usd
CY2022Q1	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	19029000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6091000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6091000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6220000	usd
CY2022Q3	irbt	Accrued Manufacturing And Logistics Costs AccruedManufacturingAndLogisticsCosts	6083000	usd
CY2022Q1	irbt	Accrued Manufacturing And Logistics Costs AccruedManufacturingAndLogisticsCosts	23038000	usd
CY2022Q3	irbt	Accrued Sales Tax AccruedSalesTax	3830000	usd
CY2022Q1	irbt	Accrued Sales Tax AccruedSalesTax	9599000	usd
CY2022Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	3493000	usd
CY2022Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	11375000	usd
CY2022Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	1665000	usd
CY2022Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	1788000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16802000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26950000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	91084000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132618000	usd
CY2022Q3	us-gaap	Revenues Revenues	255351000	usd
CY2021Q3	us-gaap	Revenues Revenues	365596000	usd
	us-gaap	Revenues Revenues	547320000	usd
	us-gaap	Revenues Revenues	668857000	usd
CY2021Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	24718000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	20095000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	26814000	usd
CY2021Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	9422000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	15241000	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	30239000	usd
CY2021Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	23904000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	32019000	usd
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	24392000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	4000000	usd
CY2021Q3	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	10236000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	10036000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	20421000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	7425000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	26814000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1800000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-32300000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.304
CY2021Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	24718000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22700000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22700000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.343
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	usd
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.171
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.343
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-32300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1800000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.615
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.304
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q3	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	140	employee
CY2022Q3	irbt	Restructuring And Related Cost Percentage Of Workforce RestructuringAndRelatedCostPercentageOfWorkforce	0.10

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001159167-22-000055-index-headers.html	Edgar Link	pending
0001159167-22-000055-index.html	Edgar Link	pending
0001159167-22-000055.txt	Edgar Link	pending
0001159167-22-000055-xbrl.zip	Edgar Link	pending
exhibit101boa-irobotxsec.htm	Edgar Link	pending
exhibit101boa-irobotxsec001.jpg	Edgar Link	pending
exhibit101boa-irobotxsec002.jpg	Edgar Link	pending
exhibit101boa-irobotxsec003.jpg	Edgar Link	pending
exhibit101boa-irobotxsec004.jpg	Edgar Link	pending
exhibit101boa-irobotxsec005.jpg	Edgar Link	pending
exhibit101boa-irobotxsec006.jpg	Edgar Link	pending
exhibit101boa-irobotxsec007.jpg	Edgar Link	pending
exhibit101boa-irobotxsec008.jpg	Edgar Link	pending
exhibit101boa-irobotxsec009.jpg	Edgar Link	pending
exhibit101boa-irobotxsec010.jpg	Edgar Link	pending
exhibit101boa-irobotxsec011.jpg	Edgar Link	pending
exhibit101boa-irobotxsec012.jpg	Edgar Link	pending
exhibit101boa-irobotxsec013.jpg	Edgar Link	pending
exhibit101boa-irobotxsec014.jpg	Edgar Link	pending
exhibit101boa-irobotxsec015.jpg	Edgar Link	pending
exhibit101boa-irobotxsec016.jpg	Edgar Link	pending
exhibit101boa-irobotxsec017.jpg	Edgar Link	pending
exhibit101boa-irobotxsec018.jpg	Edgar Link	pending
exhibit101boa-irobotxsec019.jpg	Edgar Link	pending
exhibit101boa-irobotxsec020.jpg	Edgar Link	pending
exhibit101boa-irobotxsec021.jpg	Edgar Link	pending
exhibit101boa-irobotxsec022.jpg	Edgar Link	pending
exhibit101boa-irobotxsec023.jpg	Edgar Link	pending
exhibit101boa-irobotxsec024.jpg	Edgar Link	pending
exhibit101boa-irobotxsec025.jpg	Edgar Link	pending
exhibit101boa-irobotxsec026.jpg	Edgar Link	pending
exhibit101boa-irobotxsec027.jpg	Edgar Link	pending
exhibit101boa-irobotxsec028.jpg	Edgar Link	pending
exhibit101boa-irobotxsec029.jpg	Edgar Link	pending
exhibit101boa-irobotxsec030.jpg	Edgar Link	pending
exhibit101boa-irobotxsec031.jpg	Edgar Link	pending
exhibit101boa-irobotxsec032.jpg	Edgar Link	pending
exhibit101boa-irobotxsec033.jpg	Edgar Link	pending
exhibit101boa-irobotxsec034.jpg	Edgar Link	pending
exhibit101boa-irobotxsec035.jpg	Edgar Link	pending
exhibit101boa-irobotxsec036.jpg	Edgar Link	pending
exhibit101boa-irobotxsec037.jpg	Edgar Link	pending
exhibit101boa-irobotxsec038.jpg	Edgar Link	pending
exhibit101boa-irobotxsec039.jpg	Edgar Link	pending
exhibit101boa-irobotxsec040.jpg	Edgar Link	pending
exhibit101boa-irobotxsec041.jpg	Edgar Link	pending
exhibit101boa-irobotxsec042.jpg	Edgar Link	pending
exhibit101boa-irobotxsec043.jpg	Edgar Link	pending
exhibit101boa-irobotxsec044.jpg	Edgar Link	pending
exhibit101boa-irobotxsec045.jpg	Edgar Link	pending
exhibit101boa-irobotxsec046.jpg	Edgar Link	pending
exhibit101boa-irobotxsec047.jpg	Edgar Link	pending
exhibit101boa-irobotxsec048.jpg	Edgar Link	pending
exhibit101boa-irobotxsec049.jpg	Edgar Link	pending
exhibit101boa-irobotxsec050.jpg	Edgar Link	pending
exhibit101boa-irobotxsec051.jpg	Edgar Link	pending
exhibit101boa-irobotxsec052.jpg	Edgar Link	pending
exhibit101boa-irobotxsec053.jpg	Edgar Link	pending
exhibit101boa-irobotxsec054.jpg	Edgar Link	pending
exhibit101boa-irobotxsec055.jpg	Edgar Link	pending
exhibit101boa-irobotxsec056.jpg	Edgar Link	pending
exhibit101boa-irobotxsec057.jpg	Edgar Link	pending
exhibit101boa-irobotxsec058.jpg	Edgar Link	pending
exhibit101boa-irobotxsec059.jpg	Edgar Link	pending
exhibit101boa-irobotxsec060.jpg	Edgar Link	pending
exhibit101boa-irobotxsec061.jpg	Edgar Link	pending
exhibit101boa-irobotxsec062.jpg	Edgar Link	pending
exhibit101boa-irobotxsec063.jpg	Edgar Link	pending
exhibit101boa-irobotxsec064.jpg	Edgar Link	pending
exhibit101boa-irobotxsec065.jpg	Edgar Link	pending
exhibit101boa-irobotxsec066.jpg	Edgar Link	pending
exhibit101boa-irobotxsec067.jpg	Edgar Link	pending
exhibit101boa-irobotxsec068.jpg	Edgar Link	pending
exhibit101boa-irobotxsec069.jpg	Edgar Link	pending
exhibit101boa-irobotxsec070.jpg	Edgar Link	pending
exhibit101boa-irobotxsec071.jpg	Edgar Link	pending
exhibit101boa-irobotxsec072.jpg	Edgar Link	pending
exhibit101boa-irobotxsec073.jpg	Edgar Link	pending
exhibit101boa-irobotxsec074.jpg	Edgar Link	pending
exhibit101boa-irobotxsec075.jpg	Edgar Link	pending
exhibit101boa-irobotxsec076.jpg	Edgar Link	pending
exhibit101boa-irobotxsec077.jpg	Edgar Link	pending
exhibit101boa-irobotxsec078.jpg	Edgar Link	pending
exhibit101boa-irobotxsec079.jpg	Edgar Link	pending
exhibit101boa-irobotxsec080.jpg	Edgar Link	pending
exhibit101boa-irobotxsec081.jpg	Edgar Link	pending
exhibit101boa-irobotxsec082.jpg	Edgar Link	pending
exhibit101boa-irobotxsec083.jpg	Edgar Link	pending
exhibit101boa-irobotxsec084.jpg	Edgar Link	pending
exhibit101boa-irobotxsec085.jpg	Edgar Link	pending
exhibit101boa-irobotxsec086.jpg	Edgar Link	pending
exhibit101boa-irobotxsec087.jpg	Edgar Link	pending
exhibit101boa-irobotxsec088.jpg	Edgar Link	pending
exhibit101boa-irobotxsec089.jpg	Edgar Link	pending
exhibit101boa-irobotxsec090.jpg	Edgar Link	pending
exhibit101boa-irobotxsec091.jpg	Edgar Link	pending
exhibit101boa-irobotxsec092.jpg	Edgar Link	pending
exhibit101boa-irobotxsec093.jpg	Edgar Link	pending
exhibit101boa-irobotxsec094.jpg	Edgar Link	pending
exhibit101boa-irobotxsec095.jpg	Edgar Link	pending
exhibit101boa-irobotxsec096.jpg	Edgar Link	pending
exhibit101boa-irobotxsec097.jpg	Edgar Link	pending
exhibit101boa-irobotxsec098.jpg	Edgar Link	pending
exhibit101boa-irobotxsec099.jpg	Edgar Link	pending
exhibit101boa-irobotxsec100.jpg	Edgar Link	pending
exhibit101boa-irobotxsec101.jpg	Edgar Link	pending
exhibit101boa-irobotxsec102.jpg	Edgar Link	pending
exhibit101boa-irobotxsec103.jpg	Edgar Link	pending
exhibit101boa-irobotxsec104.jpg	Edgar Link	pending
exhibit101boa-irobotxsec105.jpg	Edgar Link	pending
exhibit101boa-irobotxsec106.jpg	Edgar Link	pending
exhibit101boa-irobotxsec107.jpg	Edgar Link	pending
exhibit101boa-irobotxsec108.jpg	Edgar Link	pending
exhibit101boa-irobotxsec109.jpg	Edgar Link	pending
exhibit101boa-irobotxsec110.jpg	Edgar Link	pending
exhibit101boa-irobotxsec111.jpg	Edgar Link	pending
exhibit101boa-irobotxsec112.jpg	Edgar Link	pending
exhibit101boa-irobotxsec113.jpg	Edgar Link	pending
exhibit101boa-irobotxsec114.jpg	Edgar Link	pending
exhibit101boa-irobotxsec115.jpg	Edgar Link	pending
exhibit101boa-irobotxsec116.jpg	Edgar Link	pending
exhibit101boa-irobotxsec117.jpg	Edgar Link	pending
exhibit101boa-irobotxsec118.jpg	Edgar Link	pending
exhibit101boa-irobotxsec119.jpg	Edgar Link	pending
exhibit101boa-irobotxsec120.jpg	Edgar Link	pending
exhibit101boa-irobotxsec121.jpg	Edgar Link	pending
exhibit101boa-irobotxsec122.jpg	Edgar Link	pending
exhibit101boa-irobotxsec123.jpg	Edgar Link	pending
exhibit101boa-irobotxsec124.jpg	Edgar Link	pending
exhibit101boa-irobotxsec125.jpg	Edgar Link	pending
exhibit101boa-irobotxsec126.jpg	Edgar Link	pending
exhibit101boa-irobotxsec127.jpg	Edgar Link	pending
exhibit101boa-irobotxsec128.jpg	Edgar Link	pending
exhibit102boa-irobotxsec.htm	Edgar Link	pending
exhibit102boa-irobotxsec001.jpg	Edgar Link	pending
exhibit102boa-irobotxsec002.jpg	Edgar Link	pending
exhibit102boa-irobotxsec003.jpg	Edgar Link	pending
exhibit102boa-irobotxsec004.jpg	Edgar Link	pending
exhibit102boa-irobotxsec005.jpg	Edgar Link	pending
exhibit102boa-irobotxsec006.jpg	Edgar Link	pending
exhibit102boa-irobotxsec007.jpg	Edgar Link	pending
exhibit102boa-irobotxsec008.jpg	Edgar Link	pending
exhibit102boa-irobotxsec009.jpg	Edgar Link	pending
exhibit102boa-irobotxsec010.jpg	Edgar Link	pending
exhibit102boa-irobotxsec011.jpg	Edgar Link	pending
exhibit102boa-irobotxsec012.jpg	Edgar Link	pending
exhibit102boa-irobotxsec013.jpg	Edgar Link	pending
exhibit102boa-irobotxsec014.jpg	Edgar Link	pending
exhibit102boa-irobotxsec015.jpg	Edgar Link	pending
exhibit102boa-irobotxsec016.jpg	Edgar Link	pending
exhibit102boa-irobotxsec017.jpg	Edgar Link	pending
exhibit102boa-irobotxsec018.jpg	Edgar Link	pending
exhibit102boa-irobotxsec019.jpg	Edgar Link	pending
exhibit102boa-irobotxsec020.jpg	Edgar Link	pending
exhibit102boa-irobotxsec021.jpg	Edgar Link	pending
exhibit102boa-irobotxsec022.jpg	Edgar Link	pending
exhibit102boa-irobotxsec023.jpg	Edgar Link	pending
exhibit102boa-irobotxsec024.jpg	Edgar Link	pending
exhibit102boa-irobotxsec025.jpg	Edgar Link	pending
exhibit102boa-irobotxsec026.jpg	Edgar Link	pending
exhibit102boa-irobotxsec027.jpg	Edgar Link	pending
exhibit102boa-irobotxsec028.jpg	Edgar Link	pending
exhibit102boa-irobotxsec029.jpg	Edgar Link	pending
exhibit102boa-irobotxsec030.jpg	Edgar Link	pending
exhibit102boa-irobotxsec031.jpg	Edgar Link	pending
exhibit102boa-irobotxsec032.jpg	Edgar Link	pending
exhibit102boa-irobotxsec033.jpg	Edgar Link	pending
exhibit102boa-irobotxsec034.jpg	Edgar Link	pending
exhibit102boa-irobotxsec035.jpg	Edgar Link	pending
exhibit102boa-irobotxsec036.jpg	Edgar Link	pending
exhibit102boa-irobotxsec037.jpg	Edgar Link	pending
exhibit102boa-irobotxsec038.jpg	Edgar Link	pending
exhibit102boa-irobotxsec039.jpg	Edgar Link	pending
exhibit102boa-irobotxsec040.jpg	Edgar Link	pending
exhibit102boa-irobotxsec041.jpg	Edgar Link	pending
exhibit102boa-irobotxsec042.jpg	Edgar Link	pending
exhibit102boa-irobotxsec043.jpg	Edgar Link	pending
exhibit102boa-irobotxsec044.jpg	Edgar Link	pending
exhibit102boa-irobotxsec045.jpg	Edgar Link	pending
exhibit102boa-irobotxsec046.jpg	Edgar Link	pending
exhibit102boa-irobotxsec047.jpg	Edgar Link	pending
exhibit102boa-irobotxsec048.jpg	Edgar Link	pending
exhibit102boa-irobotxsec049.jpg	Edgar Link	pending
exhibit102boa-irobotxsec050.jpg	Edgar Link	pending
exhibit102boa-irobotxsec051.jpg	Edgar Link	pending
exhibit102boa-irobotxsec052.jpg	Edgar Link	pending
exhibit102boa-irobotxsec053.jpg	Edgar Link	pending
exhibit102boa-irobotxsec054.jpg	Edgar Link	pending
exhibit102boa-irobotxsec055.jpg	Edgar Link	pending
exhibit102boa-irobotxsec056.jpg	Edgar Link	pending
exhibit102boa-irobotxsec057.jpg	Edgar Link	pending
exhibit102boa-irobotxsec058.jpg	Edgar Link	pending
exhibit102boa-irobotxsec059.jpg	Edgar Link	pending
exhibit102boa-irobotxsec060.jpg	Edgar Link	pending
exhibit102boa-irobotxsec061.jpg	Edgar Link	pending
exhibit102boa-irobotxsec062.jpg	Edgar Link	pending
exhibit102boa-irobotxsec063.jpg	Edgar Link	pending
exhibit102boa-irobotxsec064.jpg	Edgar Link	pending
exhibit102boa-irobotxsec065.jpg	Edgar Link	pending
exhibit102boa-irobotxsec066.jpg	Edgar Link	pending
exhibit102boa-irobotxsec067.jpg	Edgar Link	pending
exhibit102boa-irobotxsec068.jpg	Edgar Link	pending
exhibit102boa-irobotxsec069.jpg	Edgar Link	pending
exhibit102boa-irobotxsec070.jpg	Edgar Link	pending
exhibit102boa-irobotxsec071.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
irbt-20220702.htm	Edgar Link	pending
irbt-20220702.xsd	Edgar Link	pending
irbtexhibit3117222.htm	Edgar Link	pending
irbtexhibit3127222.htm	Edgar Link	pending
irbtexhibit3217222.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
irbt-20220702_cal.xml	Edgar Link	unprocessable
irbt-20220702_def.xml	Edgar Link	unprocessable
irbt-20220702_lab.xml	Edgar Link	unprocessable
irbt-20220702_pre.xml	Edgar Link	unprocessable
irbt-20220702_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRBT
IROBOT CORP Stock $irbt

2022 Q3 Form 10-Q Financial Statement

#000115916722000055 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT IROBOT CORP Stock $irbt

2022 Q3 Form 10-Q Financial Statement

#000115916722000055 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT
IROBOT CORP Stock $irbt